SOUTHERN MEDICAL JOURNAL, cilt.103, sa.5, ss.428-433, 2010 (SCI-Expanded)
Objective: The effect of ezetimibe on blood lipids, oxidative stress, and fibrinolytic activity in hyperlipidemic patients was investigated after three months of therapy.